Quick Takeaways
- DG Capital Management, LLC filed SCHEDULE 13G/A for FENNEC PHARMACEUTICALS INC. Common Shares (FENC).
- Disclosed ownership: 4.1%.
- Date of event: 31 Dec 2024.
DG Capital Management, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for FENNEC PHARMACEUTICALS INC. Common Shares (FENC)
- Filing Manager
- DG Capital Management, LLC
- Reporting Manager
- DG Capital Management, LLC
- Symbol
- FENC
- Shares outstanding
- 27,187,610 shares
- Disclosed Ownership
- 1,114,692 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 12:06:52 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"DG Capital Management, LLC disclosed 4.1% ownership in FENNEC PHARMACEUTICALS INC. Common Shares (FENC) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 12:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| DG Capital Management, LLC | 4.1% | 1,114,692 | 0 | 1,114,692 | /s/ Dov Gertzulin | Dov Gertzulin, Managing Member | |
| DG Value Partners II Master Fund, LP | 3.5% | 953,407 | 0 | 953,407 | /s/ Dov Gertzulin | Dov Gertzulin, Managing Member of DG Capital Management, LLC, its investment manager | |
| Dov Gertzulin | 4.1% | 1,114,692 | 0 | 1,114,692 | /s/ Dov Gertzulin | Individually |